Evidence mapPaperPMID 40682195Full record

ArticleDiabetology & metabolic syndrome2025

Every 1,000 steps matter: incremental reductions in metabolic syndrome risk in Japanese office workers.

Yukako Yamaga, Thomas Svensson, Ung-Il Chung, Akiko Kishi Svensson

Abstract read
In one paragraph

Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yukako YamagaPrecision Health, Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, 113-8656, Japan.
Thomas SvenssonPrecision Health, Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, 113-8656, Japan. thomas.svensson@med.lu.se.ORCID http://orcid.org/0000-0003-1283-358X
Ung-Il ChungPrecision Health, Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, 113-8656, Japan.ORCID http://orcid.org/0000-0002-4691-6394
Akiko Kishi SvenssonPrecision Health, Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, 113-8656, Japan.ORCID http://orcid.org/0000-0002-2464-1932

Funding

Center of Innovation Program JPMJCE1304
6 · The paper itself

Abstract

backgroundSeveral studies have investigated the association between metabolic syndrome (MetS) and physical activity (PA). However, further research is needed using objective measures of PA in free-living conditions, while also accounting for the time-variant nature of MetS. This study aimed to: (1) investigate the association between wearable device-measured step count and 5-year MetS incidence in generally healthy Japanese participants, using annual health check-up (AHC) data and interval-censored survival analysis; and (2) assess the current, and recently revised, reference value (8,000 steps/day) of Japan's Ministry of Health, Labour and Welfare (MHLW), and (3) investigate the possibility of non-linear associations between daily step count and MetS.

methodsThis longitudinal prospective observation study identified average daily step count per year/person as the main exposure, and MetS incidence, defined according to Japanese guidelines, as the main outcome. The main analysis included 730 participants without MetS or pre-MetS at baseline. An interval-censored Cox model was applied to assess MetS incidence using time-to-event data.

resultsEvery 1,000 steps added to the average step count was significantly and inversely associated with incident MetS in adjusted models [Model 1: HR = 0.92; 95% CI: 0.85, 1.00; Model 2: HR = 0.91; 95% CI: 0.83, 0.99] (p < 0.05). The current reference value (8,000 steps/day) also indicated a significant inverse association [Model 1: HR = 0.32; 95% CI: 0.14, 0.71; Model 2: HR = 0.26; 95% CI: 0.11, 0.61] (p < 0.01). Higher daily step counts lowered the risk of MetS incidence according to the amount of steps up to a step count of 12,000, however, the dose-response effect was attenuated beyond 12,000 steps/day.

conclusionsEach additional 1,000 daily steps was associated with a 9% reduction in the risk of developing MetS among healthy participants. The reference value (8,000 steps/day) was associated with a 74% reduction in MetS risk.

Indexed as

IncidenceMetabolic syndromePhysical activityProspectiveStep countWearable device

Identifiers

PMID40682195
PMCPMC12275439

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.